PDS Biotechnology (FRA:EU6) Days Payable: 0.00 (As of Mar. 2026)

What is PDS Biotechnology Days Payable?

PDS Biotechnology FRA:EU6 -2.82% 32 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates FRA:EU6 with a GF Score™ of 32/100. The stock has 1 warning sign investors should review. Among 703 Biotechnology companies, PDS Biotechnology ranks worse than 142247.37% on this metric.

PDS Biotechnology's average Accounts Payable for the three months ended in Mar. 2026 was €3.10 Mil. PDS Biotechnology's Cost of Goods Sold for the three months ended in Mar. 2026 was €0.00 Mil.

The historical rank and industry rank for PDS Biotechnology's Days Payable or its related term are showing as below:

FRA:EU6's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 113.76
* Ranked among companies with meaningful Days Payable only.

PDS Biotechnology's Days Payable stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00). stayed the same

PDS Biotechnology Days Payable Related Terms

PDS Biotechnology Days Payable Historical Data

* Premium members only.

The historical data trend for PDS Biotechnology's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PDS Biotechnology Days Payable Chart

PDS Biotechnology Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Days Payable

Get a 7-Day Free Trial

0.00

PDS Biotechnology Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Days Payable	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

FRA:EU6 vs LTRN, AURX, VERU: Days Payable Comparison

For the Biotechnology subindustry, PDS Biotechnology's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PDS Biotechnology Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PDS Biotechnology's Days Payable distribution charts can be found below:

* The bar in red indicates where PDS Biotechnology's Days Payable falls into.

Save Embed

32GF Score

PDS Biotechnology Corp FRA:EU6

Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

PDS Biotechnology Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

PDS Biotechnology's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

	Days Payable (A: Dec. 2025 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2024 )	+	Accounts Payable (A: Dec. 2025 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2025 )	*	Days in Period
=	( (1.609	+	3.052)	/	2 )	/	0	*	365
=	2.3305					/	0	*	365
=	N/A

PDS Biotechnology's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

	Days Payable (Q: Mar. 2026 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2025 )	+	Accounts Payable (Q: Mar. 2026 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
=	( (3.052	+	3.157)	/	2 )	/	0	*	365 / 4
=	3.1045					/	0	*	365 / 4
=	N/A

Frequently Asked Questions Learn more about Days Payable →

What does a Days Payable of 0.00 mean?

PDS Biotechnology (FRA:EU6) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PDS Biotechnology and its competitors. According to the industry distribution chart, PDS Biotechnology ranks #999999 out of 703 companies in the Biotechnology industry.

Is PDS Biotechnology's Days Payable too high?

PDS Biotechnology's current Days Payable is 0.00. Based on the distribution chart, PDS Biotechnology ranks #999999 out of 703 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, PDS Biotechnology has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.

How does PDS Biotechnology's Days Payable compare to LTRN and AURX?

According to the Biotechnology industry distribution chart, PDS Biotechnology ranks #999999 out of 703 companies for Days Payable. This places PDS Biotechnology in the lower half of its industry. The industry median Days Payable is 113.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Days Payable for a Biotechnology company?

The median Days Payable among Biotechnology companies is 113.76, based on 703 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Days Payable mean?

A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PDS Biotechnology and its competitors. For the Biotechnology industry, the median Days Payable is 113.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PDS Biotechnology's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is PDS Biotechnology stock overvalued right now?

PDS Biotechnology (FRA:EU6) has a current Days Payable of 0.00. The current Days Payable is 0.00. PDS Biotechnology's overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Days Payable calculated?

Days Payable is calculated from a company's financial statements. For PDS Biotechnology (FRA:EU6), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PDS Biotechnology Business Description

Industry Healthcare Biotechnology

Comparable Companies LTRN AURX VERU TIL IBO KALA MGX HYPD APLM CNTX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges PDSB:USA

Address 303A College Road, East Princeton, NJ, USA, 08540

Website https://www.pdsbiotech.com

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.

32GF Score

Get the complete analysis for FRA:EU6

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.76

Price

View FRA:EU6 Analysis

See Days Payable data for all stocks →